Arcutis Biotherapeutics I... (ARQT)

ARQT trades at $15.79, 5.3% above the near-term max pain of $15 expiring Sep 19, 2025 (29 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($7.5-$97.5), signaling increased put positioning or downside protection. Key magnetic zone at 13 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ARQT shows a downward trend from 97.5 to 7.5, indicating bearish sentiment or hedging activity. The 360% spread signals divergent expectations across timeframes. Most levels below 15.79 may cap rallies. Strong magnetic level at 13 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.